Literature DB >> 21675404

Cancer survival in Hong Kong SAR, China, 1996-2001.

S C Law1, O W Mang.   

Abstract

The Hong Kong cancer registry was established in 1963, and cancer registration is done by passive and active methods. The registry contributed data on 45 cancer sites or types registered during 1996-2001 for this survival study. Follow-up has been carried out by passive methods with median follow-up ranging from 4-60 months. The proportion of cases with histologically verified cancer diagnosis ranged from 38-100%; death certificates only (DCOs) ranged from 0-11%; 83-99% of total registered cases were included for survival analysis. The 5-year age-standardized relative survival exceeded 100% for lip and non-melanoma skin followed by thyroid (94%) and testicular (92%) cancers. The corresponding survival for common cancers were breast (90%), colon (61%), liver and Lung (22%), nasopharynx (70%), rectum (59%) and stomach (39%). The 5-year relative survival by age group showed a decreasing trend with increasing agegroups for most cancers. A decreasing survival with increasing clinical extent of disease was noted.

Entities:  

Mesh:

Year:  2011        PMID: 21675404

Source DB:  PubMed          Journal:  IARC Sci Publ        ISSN: 0300-5038


  6 in total

1.  Abnormal expression of adhesion protein Bves is associated with gastric cancer progression and poor survival.

Authors:  Deng Luo; Hua Huang; Ming-Liang Lu; Gong-Fang Zhao; Jiang Chang; Meng-Yao Zheng; Yan Wang
Journal:  Pathol Oncol Res       Date:  2011-11-23       Impact factor: 3.201

2.  Reduced Popdc3 expression correlates with high risk and poor survival in patients with gastric cancer.

Authors:  Deng Luo; Ming-Liang Lu; Gong-Fang Zhao; Hua Huang; Meng-Yao Zheng; Jiang Chang; Lin Lv; Jin-Bo Luo
Journal:  World J Gastroenterol       Date:  2012-05-21       Impact factor: 5.742

3.  Ectopic expression of RASSF2 and its prognostic role for gastric adenocarcinoma patients.

Authors:  Deng Luo; Ting Ye; Tian-Qian Li; Peng Tang; Sha-Dong Min; Gong-Fang Zhao; Hua Huang; Jiang Chang; Yan Wang; Lin Lv; Ming-Liang Lu; Meng-Yao Zheng
Journal:  Exp Ther Med       Date:  2011-12-28       Impact factor: 2.447

4.  Survival of Cancer Patients in Northeast China: Analysis of Sampled Cancers from Population-Based Cancer Registries.

Authors:  Yanxia Li; Liya Yu; Jun Na; Shuang Li; Li Liu; Huijuan Mu; Xuanjuan Bi; Xiaoxia An; Xun Li; Wen Dong; Guowei Pan
Journal:  Cancer Res Treat       Date:  2017-02-02       Impact factor: 4.679

5.  Survival Rate of Prostate Cancer in Asian Countries: A Systematic Review and Meta-Analysis.

Authors:  Soheil Hassanipour; Hamed Delam; Morteza Arab-Zozani; Elham Abdzadeh; Seyyed Ali Hosseini; Hossein-Ali Nikbakht; Mahdi Malakoutikhah; Mohammad Taghi Ashoobi; Mohammad Fathalipour; Hamid Salehiniya; Shirin Riahi
Journal:  Ann Glob Health       Date:  2020-01-02       Impact factor: 2.462

Review 6.  The survival rate of hepatocellular carcinoma in Asian countries: a systematic review and meta-analysis.

Authors:  Soheil Hassanipour; Mouhebat Vali; Saber Gaffari-Fam; Hossein-Ali Nikbakht; Elham Abdzadeh; Farahnaz Joukar; Akram Pourshams; Afshin Shafaghi; Mahdi Malakoutikhah; Morteza Arab-Zozani; Hamid Salehiniya; Fariborz Mansour-Ghanaei
Journal:  EXCLI J       Date:  2020-01-13       Impact factor: 4.068

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.